ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish drugmaker Genmab in a $1.8 billion all-cash deal expected to… Read More
ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via an antibody and deliver a toxin or other compound to… Read More
— Kelli Burns joined Seattle-based healthcare company Accolade as its new chief information security officer. Burns comes from Bellevue, Wash.-based financial services company Symetra, where she held the same role. Burns… Read More
ProfoundBio has raised $70 million to advance two of its oncology drug candidates into clinical trial. The company is developing antibody-drug conjugates, which target cells with an antibody and deliver… Read More